MedTrace Logo

Evaluation of Using Vibrotactile Coordinated Reset for Management of Parkinson's Disease

NCT03857867 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2021-12-21

Study results available
· View outcomes & findings →

Summary

This is a study to evaluate peripheral vibrotactile coordinated reset stimulation for Parkinson's disease seeks to explore the safety and efficacy of an experimental non-invasive method to aid in the symptoms of Parkinson's disease. The purpose of the study is to verify the safety and tolerability of non-painful sensory (tactile) vibratory stimulation delivered to the fingertips of patients with Parkinson's disease.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Tactile Stimulation Glove

A glove device produces non-painful sensory (tactile) vibratory stimulation to the fingertips of Parkinson's patients.

Sponsors & Collaborators

  • Peter Tass, MD, PhD

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-12-30
Completion
2020-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03857867 on ClinicalTrials.gov